KYTX
USDKyverna Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$6.670
고가
$6.930
저가
$6.670
거래량
0.31M
기업 기본 정보
시가총액
291.5M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.57M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Wells Fargo Maintains Overweight on Kyverna Therapeutics, Raises Price Target to $31
Wells Fargo analyst Derek Archila maintains Kyverna Therapeutics with a Overweight and raises the price target from $27 to $31.
Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025
Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company's registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically meaningful
HC Wainwright & Co. Maintains Buy on Kyverna Therapeutics, Raises Price Target to $20
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Kyverna Therapeutics with a Buy and raises the price target from $10 to $20.
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis (RA) KYV-101 continues to demonstrate a
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
EMERYVILLE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases,
관련 주식
SMG
Scotts Miracle-Gro Company (The)
REFI
Chicago Atlantic Real Estate Finance Inc.
EDR
Endeavor Group Holdings Inc.
BWBBP
Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
ABNB
Airbnb Inc.
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기